Insulin action and secretion in hypertension in the absence of metabolic syndrome: model-based assessment from oral glucose tolerance test.

[1]  H. Lilliefors.  On the Kolmogorov-Smirnov Test for Normality with Mean and Variance Unknown , 1967 .

[2]  Y. Z. Ider,et al.  Quantitative estimation of insulin sensitivity. , 1979, The American journal of physiology.

[3]  K. M. Erickson,et al.  Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior. , 1980, The Journal of clinical endocrinology and metabolism.

[4]  Claudio Cobelli,et al.  Physiologic Evaluation of Factors Controlling , 1981 .

[5]  Ewart R. Carson,et al.  The mathematical modeling of metabolic and endocrine systems : model formulation, identification, and validation , 1983 .

[6]  E. H. Twizell.  The mathematical modeling of metabolic and endocrine systems: E.R. Carson, C. Cobelli and L. Finkelstein John Wiley and Sons, Chichester, Sussex, UK, 394 pp., £45.15, 1983 , 1984 .

[7]  E. Ferrannini,et al.  Insulin resistance in essential hypertension. , 1987, The New England journal of medicine.

[8]  G. Reaven.  Banting lecture 1988. Role of insulin resistance in human disease. , 1988, Diabetes.

[9]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[10]  C. Berne,et al.  Insulin resistance is a characteristic feature of primary hypertension independent of obesity. , 1990, Metabolism: clinical and experimental.

[11]  Jeppe Sturis,et al.  Estimation of Insulin Secretion Rates from C-Peptide Levels: Comparison of Individual and Standard Kinetic Parameters for C-Peptide Clearance , 1992, Diabetes.

[12]  R. Torella,et al.  Decreased insulin clearance as a feature of essential hypertension. , 1992, The Journal of clinical endocrinology and metabolism.

[13]  M Weissel,et al.  Elevated hepatic insulin extraction in essential hypertension. , 1993, Hypertension.

[14]  R. Bergman,et al.  Quantification of the Relationship Between Insulin Sensitivity and β-Cell Function in Human Subjects: Evidence for a Hyperbolic Function , 1993, Diabetes.

[15]  A. Quatraro,et al.  Hyperinsulinemia in hypertension: Increased secretion, reduced clearance or both? , 1993, Journal of endocrinological investigation.

[16]  A. Swislocki.  Impaired insulin clearance in essential hypertension. , 1994, Journal of human hypertension.

[17]  C Cobelli,et al.  Estimation of β-Cell Sensitivity From Intravenous Glucose Tolerance Test C-Peptide Data: Knowledge of the Kinetics Avoids Errors in Modeling the Secretion , 1995, Diabetes.

[18]  S M Grundy,et al.  Small LDL, atherogenic dyslipidemia, and the metabolic syndrome. , 1997, Circulation.

[19]  S. Jacob,et al.  Insulin Resistance, Hyperinsulinemia, and Blood Pressure Role of Age and Obesity , 1997 .

[20]  P. Raskin,et al.  Essential hypertension is associated with decreased insulin clearance and insulin resistance. , 1997, Hypertension.

[21]  C Cobelli,et al.  SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies. , 1998, Metabolism: clinical and experimental.

[22]  S. Grundy.  Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. , 1998, The American journal of cardiology.

[23]  G. Reaven,et al.  Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited. , 1999, Metabolism: clinical and experimental.

[24]  F. Nieto,et al.  Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus , 2000 .

[25]  C Cobelli,et al.  Insulin sensitivity from meal tolerance tests in normal subjects: a minimal model index. , 2000, The Journal of clinical endocrinology and metabolism.

[26]  S. Hunter,et al.  Insulin resistance and insulin pulsatility in essential hypertension , 2000, Journal of hypertension.

[27]  D A Follmann,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans , 2022 .

[28]  L. Ceriani,et al.  Longitudinal changes of insulin sensitivity in essential hypertension: influence of blood pressure control and familial predisposition to hypertension. , 2001, The Journal of clinical endocrinology and metabolism.

[29]  Claudio Cobelli,et al.  Oral Glucose Tolerance Test Minimal Model Indexes of β-Cell Function and Insulin Sensitivity , 2001 .

[30]  C Cobelli,et al.  Quantitative indexes of beta-cell function during graded up&down glucose infusion from C-peptide minimal models. , 2001, American journal of physiology. Endocrinology and metabolism.

[31]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[32]  Roberto Burattini,et al.  Interaction between glucose metabolism and endogenous insulin release in hypertension. , 2002, Metabolism: clinical and experimental.

[33]  R. Bergman.  Pathogenesis and prediction of diabetes mellitus: lessons from integrative physiology. , 2002, The Mount Sinai journal of medicine, New York.

[34]  Hui Chen,et al.  QUICKI is a useful index of insulin sensitivity in subjects with hypertension. , 2003, American journal of physiology. Endocrinology and metabolism.

[35]  G. Reaven,et al.  Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. , 2003, The Journal of clinical endocrinology and metabolism.

[36]  L. Lindholm,et al.  Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study) , 2003, Journal of hypertension.

[37]  A. Mari,et al.  Beta cell function and its relation to insulin action in humans: a critical appraisal , 2004, Diabetologia.

[38]  Andrea Mari,et al.  Assessment of insulin secretion in relation to insulin resistance , 2005, Current opinion in clinical nutrition and metabolic care.

[39]  Claudio Cobelli,et al.  Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals. , 2005, Diabetes.

[40]  S. Soegondo.  Atherogenic dyslipidemia and the metabolic syndrome. , 2005, Acta medica Indonesiana.

[41]  Claudio Cobelli,et al.  Insulin sensitivity by oral glucose minimal models: validation against clamp. , 2005, American journal of physiology. Endocrinology and metabolism.

[42]  Claudio Cobelli,et al.  A minimal model of insulin secretion and kinetics to assess hepatic insulin extraction. , 2006, American journal of physiology. Endocrinology and metabolism.

[43]  M. Boemi,et al.  Insulin resistance in hypertension quantified by oral glucose tolerance test: comparison of methods. , 2006, Metabolism: clinical and experimental.

[44]  Andrea Mari,et al.  Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance. , 2006, American journal of physiology. Endocrinology and metabolism.

[45]  Francesco Di Nardo,et al.  Deterioration of insulin sensitivity and glucose effectiveness with age and hypertension. , 2006, American journal of hypertension.

[46]  Lama Appesh,et al.  Metabolic safety of antihypertensive drugs: Myth versus reality , 2006, Current hypertension reports.

[47]  Claudio Cobelli,et al.  Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. , 2007, American journal of physiology. Endocrinology and metabolism.

[48]  Claudio Cobelli,et al.  Incretin effect potentiates beta-cell responsivity to glucose as well as to its rate of change: OGTT and matched intravenous study. , 2007, American journal of physiology. Endocrinology and metabolism.

[49]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .